Ionis licenses novel antisense drug for the treatment of centronuclear myopathy to Dynacure siteadmin2020-11-07T02:50:53-08:00November 9, 2017|
Dynacure joins ongoing Natural History Study in Centronuclear Myopathies with the Institute of Myology (France) siteadmin2020-11-07T02:52:13-08:00September 26, 2017|
Dynacure appoints its Management Team and members of the Board of Directors siteadmin2020-11-07T02:53:27-08:00March 9, 2017|
